CrypvuCrypto market view
Market data not licensed for redistribution.

Jetema

216080 ยท KOSDAQ ยท Medical Supplies and Other Pharmaceutical Products Manufacturing

Close
โ€“ Previous close pending (official data.go.kr feed not active yet) Live price โ†—

Source: Financial Services Commission stock price data (data.go.kr), updated once a day.

Daily price, 1 year

Key statistics

Market cap (KRW bn)โ€“
PERโ€“
PBRโ€“
ROE %-2.4
Debt ratio % (liabilities / equity)202
Revenue TTM (KRW bn)76.6
Op. profit TTM (KRW bn)3.8
Dividend yield %โ€“

Basis: market cap at โ€ฆ; equity = total equity (consolidated if available) at 2026.06.30; net income = trailing 12 months to 2026.06.30 (consolidated). PER is not shown when TTM net income is negative.

Upcoming risk events

Next 90 days for this company, plus macro events tagged with this ticker or its sector. Not a recommendation.

No scheduled risk events found (last checked 2026-10-30 19:40 KST).

See it in the full calendar โ†’

Annual results (KRW bn)

20212022202320242025
Revenueโ€“โ€“58.768.576.9
Operating profitโ€“โ€“2.64.13.8
Net incomeโ€“โ€“13.6-2.6-7.4

Quarterly results (KRW bn, 3 months)

2025Q12025Q22025Q32025Q42026Q12026Q2
Revenue15.820.620.120.416.020.1
Operating profit-0.11.81.01.2-0.72.3
Net income-4.1-2.5-2.81.9-2.41.4

Largest shareholder

As of the 2025 annual report: ๊น€์žฌ์˜ and related parties hold 30.24% of common shares.

Recent disclosures

DateFilingSummary
2026-10-29Insider / major-holder ownership report
์ฃผ์‹๋“ฑ์˜๋Œ€๋Ÿ‰๋ณด์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ(์ผ๋ฐ˜)
DART original
2026-10-21Insider / major-holder ownership report
์ฃผ์‹๋“ฑ์˜๋Œ€๋Ÿ‰๋ณด์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ(์ผ๋ฐ˜)
DART original
2026-10-15Single sales/supply contract
๋‹จ์ผํŒ๋งคใ†๊ณต๊ธ‰๊ณ„์•ฝ์ฒด๊ฒฐ
DART original
2026-10-15Single sales/supply contract
๋‹จ์ผํŒ๋งคใ†๊ณต๊ธ‰๊ณ„์•ฝ์ฒด๊ฒฐ
DART original
2026-10-12Insider / major-holder ownership report
์ฃผ์‹๋“ฑ์˜๋Œ€๋Ÿ‰๋ณด์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ(์ผ๋ฐ˜)
DART original
2026-09-30Insider / major-holder ownership report
์ž„์›ใ†์ฃผ์š”์ฃผ์ฃผํŠน์ •์ฆ๊ถŒ๋“ฑ์†Œ์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ
DART original
2026-09-30Insider / major-holder ownership report
์ฃผ์‹๋“ฑ์˜๋Œ€๋Ÿ‰๋ณด์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ(์ผ๋ฐ˜)
DART original
2026-09-30Insider / major-holder ownership report
์ž„์›ใ†์ฃผ์š”์ฃผ์ฃผํŠน์ •์ฆ๊ถŒ๋“ฑ์†Œ์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ
DART original
2026-09-28Insider / major-holder ownership report
์ž„์›ใ†์ฃผ์š”์ฃผ์ฃผํŠน์ •์ฆ๊ถŒ๋“ฑ์†Œ์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ
DART original
2026-09-28Insider / major-holder ownership report
์ž„์›ใ†์ฃผ์š”์ฃผ์ฃผํŠน์ •์ฆ๊ถŒ๋“ฑ์†Œ์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ
DART original
2026-09-21Insider / major-holder ownership report
์ž„์›ใ†์ฃผ์š”์ฃผ์ฃผํŠน์ •์ฆ๊ถŒ๋“ฑ์†Œ์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ
DART original
2026-09-15Insider / major-holder ownership report
์ฃผ์‹๋“ฑ์˜๋Œ€๋Ÿ‰๋ณด์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ(์ผ๋ฐ˜)
DART original

Past material filings and price reaction (market-adjusted)

DateFiling typeOn the news (vs. market)Next day (vs. market)20 days (vs. market)
2026-10-15Single sales/supply contract+5.0%โ€“โ€“
2026-08-13Single sales/supply contract-0.8%-0.7%+60.3%
2026-08-11Clinical trial / regulatory approval+1.5%-2.1%+47.2%
2026-07-02Clinical trial / regulatory approval+1.3%-2.2%-7.4%
2026-06-19Convertible bond issuance+1.5%-1.0%+16.0%
2026-06-19Rights offering (paid-in capital increase)+1.5%-1.0%+16.0%
2026-05-29Clinical trial / regulatory approval+12.5%-11.7%-0.2%
2026-03-10Revenue/profit change >=30% (15% large caps)+0.2%-0.0%-10.2%
2025-12-08Single sales/supply contract+0.9%-1.3%+6.8%
2025-06-25Convertible bond issuance+1.2%+1.6%+8.8%
For information only, not investment advice. Data may be delayed or inaccurate. Full disclaimer โ†’ Data: OpenDART (FSS), stock prices: official previous-day close from the Financial Services Commission (data.go.kr) and FinanceData/marcap history, index data via FinanceDataReader, FX: ECB reference rates, crypto data from Upbit, Bithumb and Binance public APIs.
Market data not licensed for redistribution.
ยฉ Crypvu ยท Crypto market view